JD.com Down Over 6%, on Pace for Largest Percent Decrease Since October 2023 — Data Talk
JD.com, Inc. Sponsored ADR Class A (JD) is currently at $26.50, down $1.70 or 6.01%
--On pace for largest percent decrease since Oct. 12, 2023, when it fell 8.27%
--Currently down two consecutive days; down 10.31% over this period
--Worst two day stretch since the two days ending Oct. 13, 2023, when it fell 10.84%
--Up 0.4% month-to-date
--Down 8.29% year-to-date
--Down 75.21% from its all-time closing high of $106.88 on Feb. 17, 2021
--Down 21.64% from 52 weeks ago (Aug. 23, 2023), when it closed at $33.81
--Down 24.88% from its 52-week closing high of $35.27 on May 17, 2024
--Up 23.58% from its 52-week closing low of $21.44 on March 5, 2024
--Traded as low as $25.85
--Down 8.3% at today's intraday low; largest intraday percent decrease since Oct. 12, 2023, when it fell as much as 9.2%
All data as of 10:51:45 AM ET
Source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
August 21, 2024 11:09 ET (15:09 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.-
What’s the Difference Between the CPI and PCE Indexes?
-
Micron Earnings: Great Guidance but Stock Now Looks Fairly Valued
-
August PCE Report Forecasts Show More Good News on Inflation
-
AI Stocks May Be Down, but Don’t Count Them Out
-
4 Stocks to Buy as the Fed Cuts Interest Rates
-
Markets Brief: The Uncertain Path to Neutral Interest Rates
-
What’s Happening in the Markets This Week
-
Where Top Stock Fund Managers Are Looking Next After the Fed Rate Cut
-
Our Top Pick for Investing in US Renewable Energy
-
How to Measure a Stock’s Uncertainty
-
How to Determine Whether a Stock Is Cheap, Expensive, or Fairly Valued
-
Why a Company’s Management and Capital Allocation Matter
-
How to Determine What a Stock Is Worth
-
How to Measure a Company’s Competitive Advantage
-
How to Think Like a Stock Analyst
-
How GLP-1 Drugs Like Ozempic Are Boosting Biopharma Stocks